Clinical trial Recruiting at 4 sites Interventional Ages 10 to 110

Using patients' own blood to reduce transfusion needs after heart surgery

Official title: The Effect of Retrograde Autologous Priming on Transfusion Requirements After Cardiac Surgery (TheRAPy): a Multiple Period Vanguard Cluster Crossover Trial

Run by Population Health Research Institute · NCT06230198 · Data updated 2026-11-12

This study is testing whether using patients' own blood during heart surgery can help reduce the need for blood transfusions compared to the usual method.

Quick facts

Study typeInterventional
Ages10 Years to 110 Years
SexAll
Enrollment4500 (estimated)
SponsorPopulation Health Research Institute
Academic / other
Locations4 sites (Winnipeg, Manitoba and 3 other locations)
StatusRecruiting
StartedDecember 4, 2024
Main results expectedJanuary 2026
Study endsNovember 2026
Registry record updatedMarch 4, 2025
Trial IDNCT06230198 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults undergoing cardiac surgery on cardiopulmonary bypass at participating hospitals.

Probably not a fit

Patients undergoing cardiac surgery at hospitals with fewer than 200 cases per year or where the surgical team does not agree to the trial protocols may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates the feasibility of implementing a routine practice of retrograde autologous priming (RAP) compared to traditional crystalloid priming during cardiac surgeries. By using patients' own blood to prime the heart-lung machine, the study aims to minimize red blood cell (RBC) loss and reduce the need for transfusions. Conducted across four hospitals, the trial will alternate between the two priming methods over 12 periods, involving approximately 4500 cardiac surgery patients. The results will inform whether a larger trial is warranted to confirm the benefits of RAP in reducing transfusion requirements.

Why it matters

Potential benefit: If successful, this approach could significantly decrease the need for RBC transfusions in cardiac surgery patients, improving patient outcomes and conserving blood resources.

How similar studies have gone: Previous smaller studies have shown that RAP can reduce RBC transfusions by significant margins, suggesting potential success for this larger trial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Hospitals completing \>200 adult cardiac surgical cases a year; (ii) 95% of cardiovascular surgery group (i.e., cardiac anesthesiologists, surgeons, and perfusionists) agree to manage patients under both autologous priming policies as per their randomization schedule for the duration of the trial.
* All patients undergoing cardiac surgery on cardiopulmonary bypass at an enrolled site during the trial period will be included in data collection.

Exclusion Criteria:

* Complete \<=200 cardiac surgical cases.
* \<95% of their cardiovascular surgery group agrees to manage patients according to either of the two policies.

Where it's running

  • St. Boniface Hospital
    Winnipeg, Manitoba, Canada
    Recruiting
  • Hamilton General Hospital
    Hamilton, Ontario, Canada
    Recruiting
  • Montreal Heart Institute
    Montreal, Quebec, Canada
    Recruiting
  • Centre Hospitalier de l&#39;Université de Montréal (CHUM)
    Montreal, Quebec, Canada
    Recruiting

Study contacts

  • Principal investigator: Jessica Spence, MD, PhD — Population Health Research Institute
  • Study coordinator: TheRAPy Study Coordinator
  • Email: therapy@phri.ca
  • Phone: 9055212100

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Head-of-bed position after clot-removal stroke therapy

    This study tests whether keeping the head of the bed flat (0 degrees) after thrombectomy improves recovery compared with a raised position in adults who had an ischemic stroke due to large vessel blockage.

    Recruiting at 2 sites Population Health Research Institute · Greater Sudbury, Ontario and 1 other locations · NCT07367633

  • Monitoring heart rhythm after noncardiac surgery

    This study is testing if wearing a portable heart monitor for up to 14 days after noncardiac surgery can help find heart rhythm problems that are often missed, to improve care for patients.

    Recruiting at 2 sites Population Health Research Institute · Hamilton, Ontario and 5 other locations · NCT06519747

  • Registry for Calcium Release Deficiency Syndrome

    This study is trying to gather information about Calcium Release Deficiency Syndrome to better understand it and find the best ways to treat people with this heart condition caused by RYR2 gene changes.

    Recruiting at 22 sites Population Health Research Institute · San Francisco, California and 21 other locations · NCT06508164

  • Surgical procedure to prevent heart rhythm issues after cardiac surgery

    This study is testing a surgical procedure to see if it can help prevent heart rhythm problems after heart surgery for patients who haven't had these issues before.

    Recruiting at 15 sites Population Health Research Institute · Louisville, Kentucky and 18 other locations · NCT06486636

  • Evaluating a diagnostic test for Calcium Release Deficiency Syndrome

    This study is testing a new way to diagnose Calcium Release Deficiency Syndrome by looking at how the heart responds to fast pacing, aiming to make diagnosis easier for patients with this condition and similar heart issues.

    Recruiting at 21 sites Population Health Research Institute · San Francisco, California and 20 other locations · NCT06188689

  • Short-term treatment with amiodarone for new atrial fibrillation after heart surgery

    This study is testing whether a short-term treatment with amiodarone can help people who develop new atrial fibrillation after heart surgery feel better and keep their heart rhythm stable.

    Recruiting at 2 sites Phase 3 Population Health Research Institute · Hamilton, Ontario and 1 other locations · NCT05841056

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.